Denis S Fedorinov

11PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersCancer geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 13, 2026
Impact of Pharmacogenetic Markers on the Efficacy of Neoadjuvant FLOT Chemotherapy in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma.

|Nov 27, 2025
Towards Personalized Chemotherapy in Gastrointestinal Cancers: Prospective Analysis of Pharmacogenetic Variants in a Russian Cohort.

Denis Fedorinov, Vladimir Lyadov, Marina Lyadova

|Aug 10, 2024
MIR27A Gene Polymorphism Modifies the Effect of Common DPYD Gene Variants on Severe Toxicity in Patients with Gastrointestinal Tumors Treated with Fluoropyrimidine-Based Anticancer Therapy.

Anna Ikonnikova, Denis Fedorinov, Dmitry Gryadunov

|Sep 13, 2022
Genotype-based chemotherapy for patients with gastrointestinal tumors: focus on oxaliplatin, irinotecan, and fluoropyrimidines.

Denis S Fedorinov, Vladimir K Lyadov, Dmitriy A Sychev

|Nov 30, 2021
Genotype-based chemotherapy for patients with gastrointestinal tumors: focus on oxaliplatin, irinotecan, and fluoropyrimidines.

Denis S Fedorinov, Vladimir K Lyadov, Dmitriy A Sychev

|Dec 21, 2020
[Analysis of carrying clinically significant allelic variants of TPMT and DPYD genes associated with the response to drug therapy in cancer practice among 9 ethnic groups of the Russian Federation].

K B Mirzaev, D S Fedorinov, K A Akmalova

Pageof 2

Frequent Collaborators

3 joint publications

Vladimir Lyadov

3 joint publications

Sherzod Abdullaev

3 joint publications

Dmitry Sychev

2 joint publications

Anastasia Kachanova